246 related articles for article (PubMed ID: 29870531)
1. Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia.
Mody A; Sikazwe I; Czaicki NL; Wa Mwanza M; Savory T; Sikombe K; Beres LK; Somwe P; Roy M; Pry JM; Padian N; Bolton-Moore C; Holmes CB; Geng EH
PLoS Med; 2018 Jun; 15(6):e1002574. PubMed ID: 29870531
[TBL] [Abstract][Full Text] [Related]
2. Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression discontinuity.
Mody A; Sikazwe I; Namwase AS; Wa Mwanza M; Savory T; Mwila A; Mulenga L; Herce ME; Mweebo K; Somwe P; Eshun-Wilson I; Sikombe K; Beres LK; Pry J; Holmes CB; Bolton-Moore C; Geng EH
Lancet HIV; 2021 Dec; 8(12):e755-e765. PubMed ID: 34656208
[TBL] [Abstract][Full Text] [Related]
3. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
[TBL] [Abstract][Full Text] [Related]
4. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
Bor J; Fox MP; Rosen S; Venkataramani A; Tanser F; Pillay D; Bärnighausen T
PLoS Med; 2017 Nov; 14(11):e1002463. PubMed ID: 29182641
[TBL] [Abstract][Full Text] [Related]
5. Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
Brazier E; Tymejczyk O; Wools-Kaloustian K; Jiamsakul A; Torres MTL; Lee JS; Abuogi L; Khol V; Mejía Cordero F; Althoff KN; Law MG; Nash D;
PLoS Med; 2024 Mar; 21(3):e1004367. PubMed ID: 38498589
[TBL] [Abstract][Full Text] [Related]
6. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
[TBL] [Abstract][Full Text] [Related]
8. Temporal changes in paediatric and adolescent HIV outcomes across the care continuum in Zambia: an interrupted time-series analysis.
Bolton-Moore C; Sikazwe I; Mubiana-Mbewe M; Munthali G; Wa Mwanza M; Savory T; Nkhoma L; Somwe P; Namwase AS; Geng EH; Mody A
Lancet HIV; 2022 Aug; 9(8):e563-e573. PubMed ID: 35905754
[TBL] [Abstract][Full Text] [Related]
9. Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.
Tymejczyk O; Brazier E; Yiannoutsos CT; Vinikoor M; van Lettow M; Nalugoda F; Urassa M; Sinayobye JD; Rebeiro PF; Wools-Kaloustian K; Davies MA; Zaniewski E; Anderegg N; Liu G; Ford N; Nash D;
PLoS Med; 2019 Jun; 16(6):e1002822. PubMed ID: 31181056
[TBL] [Abstract][Full Text] [Related]
10. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
Kerkhoff AD; Sikombe K; Eshun-Wilson I; Sikazwe I; Glidden DV; Pry JM; Somwe P; Beres LK; Simbeza S; Mwamba C; Bukankala C; Hantuba C; Moore CB; Holmes CB; Padian N; Geng EH
PLoS Med; 2020 May; 17(5):e1003107. PubMed ID: 32401797
[TBL] [Abstract][Full Text] [Related]
11. Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
Sikazwe I; Eshun-Wilson I; Sikombe K; Czaicki N; Somwe P; Mody A; Simbeza S; Glidden DV; Chizema E; Mulenga LB; Padian N; Duncombe CJ; Bolton-Moore C; Beres LK; Holmes CB; Geng E
PLoS Med; 2019 May; 16(5):e1002811. PubMed ID: 31150380
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria.
Aliyu MH; Blevins M; Parrish DD; Megazzini KM; Gebi UI; Muhammad MY; Ahmed ML; Hassan A; Shepherd BE; Vermund SH; Wester CW
J Acquir Immune Defic Syndr; 2014 Feb; 65(2):e41-9. PubMed ID: 23727981
[TBL] [Abstract][Full Text] [Related]
15. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
[TBL] [Abstract][Full Text] [Related]
16. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya.
Rosen S; Maskew M; Larson BA; Brennan AT; Tsikhutsu I; Fox MP; Vezi L; Bii M; Venter WDF
PLoS Med; 2019 Sep; 16(9):e1002912. PubMed ID: 31525187
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported reasons for declining same-day antiretroviral therapy initiation in routine HIV care settings in Lusaka, Zambia: results from a mixed-effects regression analysis.
Pry J; Chipungu J; Smith HJ; Bolton Moore C; Mutale J; Duran-Frigola M; Savory T; Herce ME
J Int AIDS Soc; 2020 Jul; 23(7):e25560. PubMed ID: 32618137
[TBL] [Abstract][Full Text] [Related]
19. Effects of National Adoption of Treat-All Guidelines on Pre-Antiretroviral Therapy (ART) CD4 Testing and Viral Load Monitoring After ART initiation: A Regression Discontinuity Analysis.
Brazier E; Tymejczyk O; Zaniewski E; Egger M; Wools-Kaloustian K; Yiannoutsos CT; Jaquet A; Althoff KN; Lee JS; Caro-Vega Y; Luz PM; Tanuma J; Niyongabo T; Nash D
Clin Infect Dis; 2021 Sep; 73(6):e1273-e1281. PubMed ID: 33693517
[TBL] [Abstract][Full Text] [Related]
20. Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study.
Herce ME; Hoffmann CJ; Fielding K; Topp SM; Hausler H; Chimoyi L; Smith HJ; Chetty-Makkan CM; Mukora R; Tlali M; Olivier AJ; Muyoyeta M; Reid SE; Charalambous S
Lancet HIV; 2020 Dec; 7(12):e807-e816. PubMed ID: 32763152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]